|
|
|
MORE REPORTS |
 |
The 4th Canadian Colloquium on Dementia was held October 18-20, 2007 in Vancouver, BC.
The 4th CCD was a meeting of professionals devoted to presenting cutting-edge research on dementia, and educating participants on trends in the diagnosis and treatment of Alzheimer’s disease and other dementias.
Please note that the online, video portions of this report require the most recent version of Adobe Flash Player, which can be obtained as a free download by
clicking here.
|
This multi-media conference report was made possible by an unrestricted educational grant from Pfizer Canada Inc. and Novartis Canada Inc.
Welcoming Remarks and Overview of the Program
The Latest Research in Dementia Care: Views from the 4th Annual Canadian Colloquium on Dementia
Speaker: Dr. Ron Keren, MD, FRCPC, 4th CCD Chair; Clinical Director,
University Health Network and Whitby Mental
Health Centre Memory Clinics; Assistant Professor,
University of Toronto,Toronto, ON.
Working Effectively with Community Partners in Dementia Care
Speaker: Dr. Carole A. Cohen, MD,FRCPC,
Associate Professor, Department of Psychiatry,
University of Toronto; Clinical Director,
Community Psychiatric Services for the
Elderly, Sunnybrook and Women’s College
Health Sciences Centre; Toronto, ON.
Alzheimer’s Disease: Treatments on the Horizon
Speaker: Dr. Serge Gauthier, MD, FRCPC,
Director, Alzheimer Disease and Related Disorders Research Unit, McGill Centre for Studies in Aging, Montreal,QC.
The Alzheimer’s Disease Symposium: Immunotherapies, the Question of Cures, and the Amyloid Hypothesis
Natural Human Antibodies for Alzheimer Disease
Speaker: Dr. Norman Relkin, MD, PhD,
Director, Cornell Memory Disorders Program, New York Presbyterian Hospital; Weill Cornell Medical College, New York.
Curing Alzheimer’s Disease: The Case of tau and GSK-3
Speaker: Dr. Simon Lovestone, PhD, MRCPsych,
Professor, Old Age Psychiatry,
MRC Centre for Neurodegeneration
Research; Departments of Old Age
Psychiatry and Neuroscience, King's College
London, Institute of Psychiatry, London,
England, UK.
The Pros and Cons of the Amyloid Hypothesis of Alzheimer’s Disease
Speaker: Andrea LeBlanc, PhD,
Professor and McGill Dawson Scholar,
Department of Neurology and
Neurosurgery, McGill University; Project
Director, Bloomfield Centre for Research
in Aging, Lady Davis Institute for
Medical Research, Sir Mortimer B.
Davis Jewish General Hospital,
Montreal,QC.
Antiamyloid Immunotherapy: What do the vessels think?
Speaker: Steven M. Greenberg, MD, PhD,
Director, Hemorrhagic Stroke
Research Program, Massachusetts General
Hospital; Associate Professor of
Neurology, Harvard Medical School,
Boston, MA, USA.
Idiopathic Normal Pressure Hydrocephalus
Speaker: Dr. Norman Relkin, MD, PhD,
Director, Cornell Memory Disorders
Program; Associate Professor of Clinical
Neurology and Neuroscience,Weill Cornell
Medical College; Associate Attending Neurologist,
NewYork-Presbyterian Hospital,
New York, NY, USA.
Dementia and Depression: The Importance of Recognizing their Relationship
Speaker: Dr. Kristine Yaffe, MD,
Associate Professor, Department of
Psychiatry, Neurology and Epidemiology;
Co-director of the Clinical and Translational
Sciences Training Program, University of
California, San Francisco; San Francisco,
CA, USA.
|
|
|
|
|
|
|
